Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F19%3AN0000053" target="_blank" >RIV/00064190:_____/19:N0000053 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/19:10395859 RIV/00669806:_____/19:10395859 RIV/00216208:11140/19:10395859
Result on the web
<a href="http://dx.doi.org/" target="_blank" >http://dx.doi.org/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.33678/cor.2019.007" target="_blank" >10.33678/cor.2019.007</a>
Alternative languages
Result language
angličtina
Original language name
Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study
Original language description
Introduction: Secondary prevention after myocardial infarction is at least as important as treatment of the acute phase. Improved cardiovascular (CV) prevention can decisively contribute to the continuation of positive trends of CV morbidity and mortality seen in the Czech Republic in last three decades. Objectives: To determine, in patients with coronary heart disease (CHD), how the treatment goals as defined by the current European guidelines on CV secondary prevention (2012) are implemented in clinical practice. Methods: Patients <= 80 years when hospitalized for acute coronary syndrome, and/or CABG or PCI were identified from hospital records and invited to outpatient clinical investigation (interview) not less than 6 months and not more than 2 years after hospital discharge. Data collection was performed based on a review of medical records and the interview. Results: Of 624 invited patients, 406 responders were interviewed. Among these, 20% were smokers, 44.8% were obese (BMI >= 30), 85.5% were overweight or obese (BMI >= 25), 70.2% had central obesity (waist circumference >= 102 cm in men, >= 88 cm in women), the recommended level of physical activity (30 minutes 5 times a week) was not attained by 85%. Raised blood pressure (>= 140/90 mmHg, in diabetics >= 140/80 mmHg) was measured in 55.1%, elevated LDL-cholesterol (>= 1.8 mmol/L) in 63.5% of responders. Manifest diabetes mellitus (known plus newly discovered at interview) was present in 41.2%, and prediabetes in 23.4% of patients. The respective figures when using the oral glucose tolerance test (OGTT) were 44.7% and 32.3%. At interview, 88.4% of patients were being treated with aspirin or other antiplatelet drugs, 81.3% with beta-blockers, 78.8% with ACE inhibitors or angiotensin receptor blockers (ARBs), 92.1% with statins, and 92.9% had undergone revascularization. Conclusion: The majority of coronary patients have unhealthy lifestyles such as unhealthy diet and sedentary behavior. The prevalence of overweight, obesity, and diabetes is very high, and prevalence of obesity further increased. Although pharmacotherapy is used in the majority of patients, the recommended levels of blood pressure, lipid, and glucose metabolism are achieved in only a minority.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/NV17-29520A" target="_blank" >NV17-29520A: Long term trends of CHD secondary prevention and risk prediction in selected sample of Czech population – Czech part of the EUROASPIRE V Study</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
COR ET VASA
ISSN
0010-8650
e-ISSN
1803-7712
Volume of the periodical
61
Issue of the periodical within the volume
3
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
7
Pages from-to
277-283
UT code for WoS article
000472526800003
EID of the result in the Scopus database
2-s2.0-85068486103